CD8A and neoplasm: Future studies will determine whether any of these signatures, or those characteristic of tumor-responsive cells in the draining lymphoid organs, are associated with provision of help to CD8+ T cells, which is essential for efficient anti-tumor responses (Ahrends et al., 2017; Bos and Sherman, 2010).